ozone has been researched along with rifampin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belianin, II; Martynova, LP; Shmelev, EI | 1 |
Belianin, II; Shmelev, EI | 2 |
Deng, Y; Luo, J; Lv, W; Sun, Y | 1 |
4 other study(ies) available for ozone and rifampin
Article | Year |
---|---|
[Dissolved ozone treatment-induced change in the resistance of multi-resistant mycobacterial strain to isoniazid and rifampicin].
Topics: Antitubercular Agents; Cells, Cultured; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Mycobacterium tuberculosis; Ozone; Rifampin; Tuberculosis, Pulmonary | 2002 |
[Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ozone; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2004 |
[Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
Topics: Adolescent; Adult; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Isoniazid; Kanamycin; Male; Mice; Mice, Inbred BALB C; Middle Aged; Mycobacterium tuberculosis; Ozone; Radiography, Thoracic; Rifampin; Streptomycin; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2007 |
Biomaterials immobilized with chitosan for rechargeable antimicrobial drug delivery.
Topics: Animals; Anti-Infective Agents; Bacteria; Biocompatible Materials; Biofilms; Cell Survival; Chitosan; Ciprofloxacin; Drug Delivery Systems; Fibroblasts; Membranes, Artificial; Microbial Sensitivity Tests; Ozone; Polyurethanes; Rats; Rats, Sprague-Dawley; Rifampin; Surface Properties; Time Factors | 2013 |